top of page
pharma naming
The Readge blog
Looking to navigate the complex world of drug naming with more confidence? The Readge Blog offers insights into regulatory naming—from INN and brand name approval to risk management and portfolio strategies.
You’ll find:
-
Practical tips for avoiding rejection by EMA, FDA and WHO
-
World wide examples of what works (and what doesn’t)
-
Strategies for building a strong, compliant name system
-
Articles and perspectives from experts around the world
Whether you're naming your first product or managing an entire portfolio, our blog gives you useful and instructive information.
NB: All images have been checked for copyright issues in advance.
Please let us know if you object to the use of a specific image, and we will remove it immediately.
Search
'Accelerated approval' drugs: How well are they studied?
When an investigational prescription drug shows promise for treating a serious illness or filling an unmet medical need, the Food and...
pharmanaming.com by Readge consultants
2 min read
The FDA just approved the first direct competitor to a billion-dollar cancer drug
As it stands right now, biosimilars can't be used interchangeably with branded versions, meaning if you were to get a prescription for a branded biologic, you wouldn't be able to opt for the "generic" one at the pharmacy as easily as you could if the drug was, say, a statin. The FDA just approved a version of Avastin, a blockbuster chemotherapy made by Genentech that brought in $6.7 billion in sales in 2016. The newly approved drug, made by Amgen, will go by the marketed nam
pharmanaming.com by Readge consultants
2 min read
Role of brand is 57% more likely to influence a recommendation compared to two years ago
A new report conducted by health branding agency InterbrandHealth measures the value that brands alone provide pharmaceutical companies....
pharmanaming.com by Readge consultants
2 min read
What’s in a name? Billions of dollars in tech costs for biosimilars
A new US FDA guidance on how biological products licensed under the Public Health Service Act (PHS Act) need to be named is playing havoc...
pharmanaming.com by Readge consultants
5 min read
How drug development is speeding up in the cloud
Developing a drug from a promising molecule to a potential life-saver can take more than a decade and cost billions of dollars. Speeding...
pharmanaming.com by Readge consultants
4 min read
Globalization in the pharmaceutical industry
Where are drugs invented, and how can easily innovation be seeded in new areas? This is the first of DrugPatentWatch's publications...
pharmanaming.com by Readge consultants
2 min read
Why Biosimilar Drug Names Contain Unhelpful Gibberish
Have you ever wondered how drugs are named? Is there ever a discernible meaning behind drug names? Who manages this mess anyway–drug...
pharmanaming.com by Readge consultants
4 min read
Behind potent drug names, a complex mix of ingredients
Firms must navigate legal and linguistic hurdles for approval They are the public face of products that can take many years and hundreds...
pharmanaming.com by Readge consultants
4 min read
Introducing The New Association For Accessible Medicines (AAM)
The Generic Pharmaceutical Association (GPhA), the US largest trade group representing generic pharmaceutical and biosimilar companies,...
pharmanaming.com by Readge consultants
3 min read
FDA Reiterates Decision on Suffixes in Biosimilar Naming
A Federal Register notice from FDA addressed comments on the guidance on Proprietary Naming of Biological Products and the agency’s...
pharmanaming.com by Readge consultants
2 min read
Behind potent drug names, a complex mix of ingredients
Drug names start out as alien words: random collections of syllables that can sometimes seem almost as mind-boggling as the complicated...
pharmanaming.com by Readge consultants
4 min read
New diagnostic name for stigmatizing term obesity
The American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) proposed Adiposity-Based Chronic...
pharmanaming.com by Readge consultants
9 min read
The creative science of coining drug names
With more than 30,000 proprietary drugs in the United States alone, coming up with a unique brand name is no easy task. Cialis, Eliquis,...
pharmanaming.com by Readge consultants
4 min read
UK medicines regulation: responding to current challenges
The medicines regulatory environment is evolving rapidly in response to the changing environment. Advances in science and technology have...
pharmanaming.com by Readge consultants
13 min read
Probiotics in Favor of Life
We all use the term “probiotic" so often, but may not think of what it means. The Russian Nobel Laureate Elie Metchnikoff, best known for...
pharmanaming.com by Readge consultants
3 min read
Maintaining Relevance In The Age Of Consumerism: Lessons From The Healthcare Industry
The rise of global consumerism has shifted the healthcare landscape tremendously. People expect sophisticated levels of transparency and...
pharmanaming.com by Readge consultants
4 min read
'Creation engineering': The art and science of naming drugs
CNN)Yearly lists of the "most popular baby names" show how tastes change over time. While Jennifer, Heather, Michael and Jason may have...
pharmanaming.com by Readge consultants
9 min read
Neuropathy: A name for their pain
People with neuropathic pain have struggled to find relief with conventional drugs. Researchers are investigating whether more meaningful...
pharmanaming.com by Readge consultants
7 min read
FDA approves first automated insulin delivery device for type 1 diabetes
The U.S. Food and Drug Administration today approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device...
pharmanaming.com by Readge consultants
3 min read
How drug startups choose their brand
The intellectual property is secure. The science is sound. You’re about to make your pitch for funding. The scary next step for a biotech...
pharmanaming.com by Readge consultants
4 min read
bottom of page